GB1462545A - Feline rhinotracheitis vaccine and production thereof - Google Patents

Feline rhinotracheitis vaccine and production thereof

Info

Publication number
GB1462545A
GB1462545A GB1220775A GB1220775A GB1462545A GB 1462545 A GB1462545 A GB 1462545A GB 1220775 A GB1220775 A GB 1220775A GB 1220775 A GB1220775 A GB 1220775A GB 1462545 A GB1462545 A GB 1462545A
Authority
GB
United Kingdom
Prior art keywords
feline
production
feline rhinotracheitis
tissue cultures
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1220775A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of GB1462545A publication Critical patent/GB1462545A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Virulent feline rhinotracheitis virus is attenuated by at least 7 serial passages in feline tissue cultures in a nutrient liquid at 30+/-2 DEG C. The attenuated virus is subjected to further serial passages in feline tissue cultures in a nutrient liquid at 32 to 37 DEG C until the titre reaches 10<4> to 10<7> TCID per ml. The liquid vaccine provides protection against viral rhinotracheitis in cats.
GB1220775A 1974-03-25 1975-03-24 Feline rhinotracheitis vaccine and production thereof Expired GB1462545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45434574A 1974-03-25 1974-03-25

Publications (1)

Publication Number Publication Date
GB1462545A true GB1462545A (en) 1977-01-26

Family

ID=23804244

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1220775A Expired GB1462545A (en) 1974-03-25 1975-03-24 Feline rhinotracheitis vaccine and production thereof

Country Status (12)

Country Link
JP (1) JPS50154415A (en)
AT (1) AT340583B (en)
AU (1) AU502636B2 (en)
BE (1) BE827157A (en)
CA (1) CA1058074A (en)
CH (1) CH618091A5 (en)
DE (1) DE2512903A1 (en)
ES (1) ES436028A1 (en)
FR (1) FR2265405B1 (en)
GB (1) GB1462545A (en)
NL (1) NL7503499A (en)
ZA (1) ZA751854B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
DE2544510A1 (en) * 1975-10-04 1977-04-14 Philips Nv Feline rhinotracheitis vaccine - by attenuation of live virus by serial passage at 25 degree C in cat kidney cells
FR2327799A1 (en) * 1975-10-17 1977-05-13 Philips Nv Feline rhinotracheitis vaccine - by attenuation of live virus by serial passage at 25 degree C in cat kidney cells
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
JPS60196187A (en) * 1984-03-16 1985-10-04 Biseibutsu Kagaku Kenkyusho:Kk Attenuated strain of bovine rs virus

Also Published As

Publication number Publication date
DE2512903A1 (en) 1975-10-02
ATA219075A (en) 1977-04-15
CH618091A5 (en) 1980-07-15
BE827157A (en) 1975-09-25
ZA751854B (en) 1976-10-27
AU502636B2 (en) 1979-08-02
NL7503499A (en) 1975-09-29
JPS50154415A (en) 1975-12-12
AT340583B (en) 1977-12-27
CA1058074A (en) 1979-07-10
FR2265405B1 (en) 1978-07-28
FR2265405A1 (en) 1975-10-24
ES436028A1 (en) 1978-06-01
AU7944675A (en) 1976-09-30

Similar Documents

Publication Publication Date Title
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
JPS55153723A (en) Manufacture of influenza virus vaccine in liquid cell culture
GB1292803A (en) Improvements relating to the production of antigens
ES486442A0 (en) A METHOD OF PREPARING A VACCINE CONTAINING AN ATTACHED STRAIN OF FELINE INFECTIOUS PERITONITIS VIRUSES.
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
Gillespie et al. In vitro protective effect of bacteria-derived bovine alpha interferon I1 against selected bovine viruses
ZA805849B (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
JPS5756430A (en) Live virus vaccine for canine parainfluenza
IL67818A (en) Vaccines comprising ozone inactivated viruses and their production
Smith et al. Persistent rubella virus production in embryonic rabbit chondrocyte cell cultures
GB846755A (en) Bovine rhinotracheitis vaccine and methods of production
ES471766A1 (en) Parainfluenza virus vaccine and its preparation.
ES460321A1 (en) Production of mutant of aujeszky&#39;s virus
Budowsky et al. Principles of selective inactivation of the viral genome. III. Kinetic of bacteriophage MS 2 infectivity inactivation by beta-propiolactone.
JPS5746923A (en) Inactivated vaccine for dog parvoviral infectious disease
IT1041774B (en) Feline rhinotracheitis vaccine - by attenuation of live virus by serial passage at 25 degree C in cat kidney cells
FR2327799A1 (en) Feline rhinotracheitis vaccine - by attenuation of live virus by serial passage at 25 degree C in cat kidney cells
NL7408579A (en) Vaccine against respiratory infections esp in horses - contg an adsorbed, killed suspension of reovirus in water
NL7511136A (en) Prodn. of attenuated feline rhinotracheitis virus - for vaccine prepn.
Zmudzinski et al. The vaccine of Polish production against myxomatosis of rabbits.
FR2290220A2 (en) Antirabies vaccine for veterinary use - prepd. by cultivating virus on foetal calf kidney cells in medium of hydrolysed lactalbumin and calf serum

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19950323